Skip to main content
. Author manuscript; available in PMC: 2020 Sep 18.
Published in final edited form as: Lancet HIV. 2018 Jul 17;5(8):e427–e437. doi: 10.1016/S2352-3018(18)30104-8

Table 4:

CD4 cell count and HIV viral load in HIV positive men and women in a rural and peri-urban community in KwaZulu-Natal, South Africa, 2014–2015

Women
(N=2955)a
Men
(N=1014)a
n Population-weighted %,(95% CI) n N Population-weighted %, (95% CI)
Overall CD4 cell count (cells per μL)
 <200 247 8·0 (6·7–9·3) 178 17·2 (13·9–20·5)
 200–349 449 15·1 (13·6–16·7) 261 23·9 (20·4–27·3)
 350–499 639 21·1 (19·0–23·1) 243 23·9 (20·5–27·2)
 >500 1594 55·8 (53·6–58·1) 327 35·1 (31·3–38·9)
On antiretroviral therapy (cells per μL)b
 <200 75 5·6 (4·1–7·1) 54 17·0 (12·0–21·9)
 200–349 164 13·6 (11·2–16·0) 90 24·7 (18·6–30·7)
 350–499 267 20·6 (17·5–23·7) 82 23·6 (17·9–29·4)
 >500 737 60·2 (56·4–64·0) 114 34·8 (28·9–40·6)
Not on antiretroviral therapy (cells per μL)b
 <200 172 10·1 (8·1–12·1) 124 17·3 (12·8–21·8)
 200–349 285 16·4 (14·1–18·7) 171 23·4 (19·3–27·4)
 350–499 372 21·5 (18·7–24·3) 161 24·0 (19·3–28·8)
 >500 856 52·0 (49·0–55·0) 213 35·3 (30·3–40·3)
a

CD4 cell count data are missing for 27 women and five men.

b

Self-report.

HHS Vulnerability Disclosure